Rameckers EAA, Speth LAWM, Duysens J, Vles JSH, Smits-Engelsman BCM: Kinematic aiming task: measuring functional changes in hand and arm movements after botulinum toxin-a injections in children with spastic hemiplegia. Am J Phys Med Rehabil 2007;86:538 -547. Objective: To describe different aspects of a kinematic aiming task (KAT) as a quantitative way to assess changes in arm movements within 2 wks after botulinum toxin-A (BTX-A) injections in children with spastic hemiplegia.
Chi ldren with congenital spastic hemiplegia show poorer manual skills with their affected side. 1 The most frequently mentioned causes for this loss of function are related to degrees of spasticity and increased muscle tone, 2 decreased muscle power, 3 and decreased muscle length. 4 A lot of research has been directed to the functional relation between spasticity and manual skills in children with cerebral palsy (CP). 2, 6 Level of spasticity is most often graded by the Ashworth scale (AS) and the Tardieu test (TT). 7, 8 Reduction of spasticity, however, is not automatically related to improvement in manual skills. 9 Indeed, low correlations have been found between levels of spasticity and outcome measures of skilled motor control. 10 -12 Several explanations for this low correlation have been put forward. Both AS and TT score the increased resistance against a high-velocity stretch. The TT uses the difference between the joint angle at the moment of the high-velocity resistance (stretch restricted angle [SRA]) and the low-velocity angle (passive restricted angle [PRA]) as a measure of the dynamic component of muscle tone abnormality. 12 However, this increased resistance is probably not just a measure of spasticity. It is also related to myogen and collagen stiffness. 4, 14, 15 Scholtes et al. 12 even have stated that the solitary use of the SRA for evaluation of treatment of spasticity is probably better because of the interest in highvelocity stretch as a measurement of velocity-dependent resistance. Damiano et al. 16 have shown that the TT seems to be somewhat task dependent. TT was measured by resistance torque at three velocities, during passive knee flexion and extension, combined with EMG. TT showed weak to moderate relationships with knee motion during gait. This underlines the need to have performance tasks that are close to daily life behavior. Related to the leg, such studies are performed using gait parameters to quantify change in walking performance. 11 In accordance with the walking performance, we developed a visual guided aiming task with quantitative parameters as speed and accuracy to measure whether differences in the parameters of the arm movements could be reproduced reliably over time, and whether the task would be sensitive enough to measure change after intervention. This task, which has been called the kinematic aiming task (KAT), uses two simple visual guided aiming movements, with low memory and cognitive load. 17, 18 In many ADL tasks, the reaching, grasping, and pointing of objects are part of the task. Therefore, this task focuses on grasping and holding an object as well as transferring it with one hand to a new target position and adapting the movement to the task requirements. In the present study, we are specifically interested in subtle quantitative changes after botulinum toxin-A (BTX-A) injections, because of the ascribed effect in reducing spasticity and muscle force. 19, 20 To test our KAT, we measured changes in the performance of children with spastic hemiplegia with the affected hand, before and after BTX-A injection in the muscles of the wrist and elbow, compared with a nontreatment group.
We wanted to test the following questions: 
METHODS Participants
For this study, the same children were enrolled as in the study of Speth et al. 21 : namely, 20 children with CP (aged 4 -16 yrs [mean 9.5] with diagnoses of hemiplegia according to Hagberg classification 22 and the hand function according to Zancolli classification (pattern I, IIa, or IIb). 23 Zancolli patterns are described as Children with hand function according to Zancolli III were excluded because of their inability to extend the wrist and actively grasp and hold an object with the affected hand. No children with asymmetric mild quadriplegia or diplegia were included in this study. Table 1 provides an overview of the baseline characteristics of the participants. The parents gave informed consent, and the medical ethics committee of the Rehabilitation Foundation Limburg approved the study.
Design
Matching according to age and Zancolli level resulted in ten pairs of children. One child of every pair was randomly allocated to either the treatment or the nontreatment group. 21 Each child was tested two times. First, the baseline measurement was administered. Then, after 1 mo, each child was tested again. For the treatment group this meant the baseline measurement was taken about 14 days before the child received BTX-A, and the second measurement was taken about 14 days after BTX-A.
The examination consisted of spasticity assessment (AS and SRA), passive and active range of motion (PROM and AROM), MVC, and the visually guided aiming task (KAT).
Injection Technique and Dosage
Botox from Allergan was used (dilution 5 U/0.1 ml). Dosage was 2-3 U/kg body weight per muscle in the upper arm, 1-2 U/kg body weight per muscle in the forearm, with a maximum of 50 U at any one injection site, with an overall maximum dose of 400 U per total body weight. 24 Predominantly, the m. adductor pollicis (10 U), the m. flexor carpi ulnaris (2 ϫ 20 U to 2 ϫ 40 U), and the m. pronator teres (30 -50 U) were injected, and less frequent injections were given in the m. flexor carpi radialis (30 U to 2 ϫ 30 U), m. biceps brachialis (2 ϫ 20 U to 2 ϫ 50 U), m. brachioradialis (40 U to 2 ϫ 40 U), and m. flexor pollicis brevis (5 U) . The number of units per total body weight varied from 2.9 to 5.8 U.
For a more detailed description of dose and localization, see Speth et al. 21 
Outcome Measures
Outcome measures are divided according to measures of the level of function and the level of activity, according to the International Classification of Functioning, Disability and Health. 25
Function Level Muscle Tone
Spasticity was measured in supine position using the AS and SRA. The muscle tone of wrist the and elbow were measured with the original five-point AS. 7 The SRA was assessed by moving the wrist and elbow as quickly as possible (within 1 sec) through the whole range of motion. 26 
Range of Motion

AROM and PROM of the elbow and wrist were measured in a sitting position, using the same goniometry Muscle Force
Muscle force was evaluated using a method that has been described previously. 28 The MVC of the finger and wrist flexors was measured (in newtons) in a task in which subjects had to apply maximum pressure onto the end of a high-quality strain lever. The pressure was transmitted onto a force transducer.
Activity Level
Kinematic Aiming Tasks
The kinematic aiming tasks (KAT) consisted of two different kinds of tasks: the discrete task and the continuous task.
One task was called the discrete task and focused on precision in performance. This task is expected to be sensitive to adaptations in force recruitment. In the discrete task, the children had a custom-made puppet (7-cm height, 2.5-cm width) in their spastic hand and could directly see their movements. An LCD screen, which could record the x and y coordinates of the moving object, was placed in horizontal position in front of the child. Oasis software 29 was used to program four conditions, which were expected to be easy enough for children with spastic hemiplegia to perform. The conditions were (a) movement for 10 cm to a 5-cm target (condition 1); (b) movement for 10 cm to a 2.5-cm target (condition 2); (c) movement for 20 cm to a 5-cm target (condition 3); and (d) movement for 20 cm to a 2.5-cm target (condition 4).
The goal for the children was to get the puppet (2.5-cm diameter) exactly in the target circle (2.5or 5-cm diameter) while performing a substantial arm movement (10 or 20 cm) on a digitizer (Wacom, type Cintiq 18sx, sample rate 206 Hz). This digitizer served as an SXGA full 24-bit color LCD monitor. The surface of the digitizer was made of glass, which made the sliding movement very easy to perform. This is illustrated in Figure 1 . After putting the puppet on the digitizer in the starting circle, the investigator pressed the start button. After a random period (0.5-1.5 secs), a tone sounded and the target appeared on the digitizer. This was the go signal for the child, who was then required to move as quickly and as accurately as possible to the target by shifting the puppet to the target that had appeared on the other side. After placing the puppet in the target, the child had to stop and wait for a new auditory go signal. Ten movements were made in each condition. The four conditions were presented in the same order with increasing difficulty (conditions 1, 2, 3, and 4). After a practice session, the experiment started.
After a practice session, the experiment started.
The second task, termed the continuous task, focused on movement speed; within 20 secs, as many movements as possible had to be made between the presented targets in the same four conditions.
After putting the puppet on the left side of the digitizer in the starting target area, the investigator pressed the start button. After a random period (0.5-1.5 secs), a tone sounded, and the right target appeared on the digitizer. This was the go signal for a series of back-and-forth movements between two positions. Because the starting position was still visible, it was possible to come back to the start position after reaching the target. After 20 secs, an automated auditive stop signal was given. Conditions were presented in the same order as in the discrete task. Discrete and continuous tasks were randomly performed, and after each task, a rest of at least 2 mins was included.
Signal Analysis
In the KAT, both movement speed and accuracy are combined. The relationship between movement speed and accuracy in goal-directed movements is expressed in the speed-accuracy tradeoff. 30 This can be used to equate the processing ability or performance of the motor system by the Index of Performance Effective (IP-E). In for- mula format, the definition is:
where a and b are empirical constants, A ϭ distance between targets, ETW ϭ effective target width, and MT ϭ movement time. The ETW is calculated as the target size plus the distance between the center of the target and the center of the puppet. 31 Movement time (secs) per segment was computed from the moment the puppet left the start area until it entered the target area. Spatial accuracy was calculated in two ways: first as a clear dichotomy between the correct (hit) and incorrect (no hit) ending of the movement within the target area (percentage of successful movements [PSM]). Second, the distance of the center of the puppet to the center of the target area was calculated. This distance was taken as a measure for end point spread (END). IP-E (bits/sec) was calculated.
Statistics
Reproducibility of both KAT and MVC measurement were measured with intraclass corre-lation (ICC) for the nontreatment group within 1 mo.
The dependent variables PSM, END, MT, and IP-E were evaluated by means of the general linear model (polynomial), repeated-measures design, with group (2) and session (2) as between-subjects variables and task (2), amplitude (2), and target size (2) as within-subject variables. Alpha level was set at 0.05. Post hoc analysis was done when appropriate.
The changes between the two measurements of the baseline values of MVC, SRA, AROM, and PROM of the elbow and wrist also were calculated. Because of the non-Gaussian distribution of the data, the Mann-Whitney U test was used to assess the differences in the changes from baseline to the second measurement between the two groups.
Spearman rank correlation was used to examine whether clinical measures (AS, SRA, AROM, PROM, and MVC) at baseline correlated with the PSM, END, MT, and IP-E in both KATs. Statistical significance was set at 0.01 to account for the use of multiple comparisons.
RESULTS
No significant differences between groups were found for any of the baseline variables.
Reproducibility (Test-Retest Reliability)
An overview of ICCs of the PSM, END, MT, and IP-E in both KATs and of MVC in the MVC task is given in Table 2 . High ICCs were found for all outcome measures in both KATs and in the MVC task, indicating a high reproducibility.
Correlation Between Clinical Measures and Functional Outcome Measures
At baseline, the outcome measures of the KAT were correlated with the AS, SRA, AROM, PROM, and MVC. The only significant correlation was seen in AROM of the wrist with PSM and END in both tasks (for P values, see Table 3 ). No significant correlation was found with any of the tests to score spasticity, illustrating the lack of correlation between KAT outcome measures and clinical measures. 
Effect of BTX-A
As seen in Table 4 , no significant changes in differences were measured after BTX-A between the treatment and nontreatment groups on SRA, AROM, and PROM. However, a significant median decrease in MVC of 4 N (minimum: 0.9; maximum: 8.5) (P Ͻ 0.001) occurred in the treatment group; no change was observed in the nontreatment group.
PSM and END
The first important property of the KAT was that both different tasks were easy enough for the children to perform successfully with their affected hand. Generally, children in both tasks reached the target in 70% (SD 29) of the movements. The treatment group succeeded at baseline in 71.7% (SD 29) of the movements and post-BTX-A 69.3% (SD 28), the nontreatment group (69.7% (SD 28) and 69.4% (SD 29). The treatment group showed a nonsignificant decrease of 2.4% after BTX-A. This was mainly caused by the most difficult condition (2.5-cm target, 20-cm distance) in both tasks. A main effect for task was found (F 1,36 ϭ 40.69, P Ͻ 0.001), indicating that the tasks differed in accuracy. For the treatment group, the PSM changed in discrete tasks from 82.9% (SD 24) to 79% (SD 23) and in continuous tasks from 60.6% (SD 31) to 59.6% (SD 30). In the nontreatment group, these values were 75.7% (SD 27) and 76.8% (SD 26) in discrete tasks and 63.7% (SD 28) and 62.1% (SD 32) in the continuous tasks.
When examining END, a main effect for task was again found (F 1,36 ϭ 5.15, P Ͻ 0.03), along with an interaction with group, session, target size, and target width (F 1,36 ϭ 4.95, P Ͻ 0.04), indicating that both groups had different spreads of the end points in different conditions after BTX-A, but approximately equal END values in the discrete task (1.5 cm [SD 0.8]) and in the continuous task (1.8 cm [SD 0.9]).
Post hoc analysis of combined tasks did show a significant interaction with group, session, target size, and target width (F 1,76 ϭ 5.334, P Ͻ 0.03). As shown in Figure 2 , an increase in END occurred after BTX-A, especially for the large movements, 
FIGURE 2 End point spread for both treatment groups (A) and nontreatment groups (B) for both KAT tasks
combined (discrete and continuous), pre (baseline) and post (post-BTX-A or second measurement). Condition 1 ϭ (target width 5 cm, target distance 10 cm); condition 2 ϭ (target width 5 cm, target distance 20 cm); condition 3 ϭ (target width 2.5 cm, target distance 10 cm); and condition 4 ϭ (target width 2.5 cm, target distance 20 cm). Bars represent 1 SE. *Significant at 0.05 level.
indicating that larger amplitudes led to poorer accuracy after BTX-A.
Movement Time
Main effects for task (F 1,36 ϭ 80.49, P Ͻ 0.001), target width (F 1,36 ϭ 68.95, P Ͻ 0.001), and target size (F 1,36 ϭ 22.38, P Ͻ 0.001) were found for this parameter. A trend for differences with session, group, target size, and width and task occurred (F 1,36 ϭ 3.01, P ϭ 0.09). As seen in Figure 3 after BTX-A, the treatment group moved slightly more slowly in the discrete task
FIGURE 3 Movement time for both treatment groups (A and C) and nontreatment groups (B and D) in discrete
and continuous tasks, pre (baseline) and post (post-BTX-A or second measurement). Condition 1 ϭ (target width 5 cm, target distance 10 cm); condition 2 ϭ (target width 5 cm, target distance 20 cm); condition 3 ϭ (target width 2.5 cm, target distance 10 cm); and condition 4 ϭ (target width 2.5 cm, target distance 20 cm). Bars represent 1 SE. As can seen in panels B and D, the reproducibility of this task is high.
FIGURE 4 Index of performance effective (IPE) for both treatment groups (A and C) and nontreatment groups
(B and D) in discrete and continuous tasks, pre (baseline) and post (post-BTX-A or second measurement). Condition 1 ϭ (target width 5 cm, target distance 10 cm); condition 2 ϭ (target width 5 cm, target distance 20 cm); condition 3 ϭ (target width 2.5 cm, target distance 10 cm); and condition 4 ϭ (target width 2.5 cm, target distance 20 cm). Bars represent 1 SE. As can be seen for controls, the reproducibility of this task is high. *Significant at 0.05 level. and more quickly in the continuous task, except for the most difficult condition (target 25 cm, distance 20 cm).
IP-E
A significant interaction for IP-E between task, target size, distance, group, and session was found (F 1,36 ϭ 6.09, P Ͻ 0.03), indicating that performance was different for both groups, tasks, and sessions.
As can be seen in Figure 4 , controls performed similarly in both tasks in all conditions. The treatment group, however, showed a slight decrease in performance in the discrete task, which focused on accuracy, in all conditions. In the continuous task, which is targeted on speed, a slight increase in performance was shown in the treatment group after BTX-A, except for the most difficult (target 2.5 cm, distance 20 cm) condition. After BTX-A, the treatment group showed a specific decrease in that most difficult condition of IP-E (0.5 bits/sec). Post hoc analysis showed that only in the continuous task, an interaction with session, group, target width, and size was reliable (F 1,36 ϭ 9.58, P Ͻ 0.005).
DISCUSSION
Our study describes two different tasks of the KAT to assess functional changes in the hand and arm movements in a quantitative way within 2 wks after BTX-A in children with spastic hemiplegia.
The first aim was to determine whether the outcomes of the KAT were stable over time. As seen in Table 4 , the ICCs for the KAT are high for the nontreatment group when tested within 1 mo. The high reproducibility indicates that the KAT is an adequate instrument to measure quantitative changes in manual ability of the spastic arm. Furthermore, the high percentage of correct trials showed that neither task is too complex for children with spastic hemiparesis.
No significant correlations were found between spasticity scores at baseline (AS and SRA) and kinematic outcomes in the KAT. One possible reason for this lack of correlation is that the measured resistance is composed of several factors such as spasticity, muscle stiffness, and contractures. 15 Furthermore, one may expect that scores obtained by passive tests, such as AS and PRA, are not comparable and, therefore, are not fully predictive of measures obtained during active motor control tasks, 2, 17 or that AS and SRA are not usable tests.
However, significant correlations were found between wrist AROM with PSM and END in the KAT, suggesting that wrist AROM is probably more predictive of manual task performance than is muscle tone. If a greater wrist AROM was present, a higher PSM and a lower END were seen. This indicates that wrist AROM might be more important for selecting patients for treatment than AS or SRA, and it might indicate good selective motor control of the wrist.
With respect to the questions about the direct effects of BTX-A, a significant reducing effect was confirmed by the significant decrease in MVC of the forearm flexors within 2 wks after BTX-A injections. This decrease in MVC is caused by decreased M-reflex and the blocking of a large number of motor units after BTX-A in the injected muscles, thus introducing "paresis." 18, 32 A nonsignificant reduction in muscle tone and increase in AROM has already been shown in the study of Speth et al. 21 One possible reason for the lack of significance could be that the treatment group was heterogeneous and too small. In other placebo-controlled studies, significant shortterm effects on the muscle tone and AROM of the wrist after BTX-A (2-6 wks) have been shown for spasticity. 33, 34 The most important question was whether there is a detectable effect of BTX-A on the KAT outcome measures. The PSM did change slightly in the treatment group (small decrease of 2.9% after injections) in both tasks, and the nontreatment group maintained the same percentage of PSM. Overall, the treatment group showed increases in END after BTX-A injections, and this effect was significant in the most difficult condition. No changes were seen in the nontreatment group. If more accuracy was asked and more distance had to be covered, END enlarged after BTX-A. Overall, MT showed no significant change. MT increased in the discrete task, but in the continuous task a decrease was seen, except for the most difficult condition. This difference in MT between the two tasks leveled out the effect over all conditions. Because of BTX-A, a lower speed induced muscle hypertonia, and increases in AROM and PROM were expected, creating the possibility for faster movements, especially in an ongoing movement task such as the continuous task. Indeed, this was found in all conditions except for the most difficult condition, in which the opposite occurred. Probably, the specific demand of accuracy in the most difficult condition was so high that MT had to increase. 30 In the discrete task, the movement time increased in all conditions, indicating that the accuracy demand and the exact braking within the target area slowed down the movement. The increase of movement time in the discrete task could also be explained by a decrease of muscle power after BTX-A. When less muscle activity can be generated and discrete movements are required, MT can increase if the accuracy demand is high and if more force is needed to control the movement. 35, 36 In the continuous task, in contrast, accuracy demands are not high, and the effects of a decrease of muscle tone seem to be more beneficial than the negative impact caused by loss of force.
With respect to the IP-E in the continuous task, an expected increase occurred after BTX-A, because the children were able to move more quickly. A decrease in IP-E occurred only in the most complex condition, when the accuracy demand was very high. In general, performance after BTX-A decreased in the discrete task. Again, an increased accuracy demand results in decreased performance after BTX-A.
Limitations of the KAT
The presentation of the tasks in the same order with increasing difficulty was chosen because randomization made the test far too confusing for the children, and they had difficulty complying with the demands. Possibly, fatigue at the moment of the last, most complex condition could occur. However, the results on END and MT showed no clear indication for fatigue. If fatigue had occurred, more END would have been expected in the last test condition, and MT would have increased. This was not observed. In fact, END was lower for the most difficult condition 1.3 (SD 0.6) than for the most easy condition 1.5 (SD 0.9). MT did increase slightly from 0.7 (SD 0.2) to 1 (SD 0.3) in the most difficult condition.
CONCLUSION
The KAT seems to be an adequate, reproducible way to quantify functional changes after BTX-A in the upper limb, especially in the most complex condition and in the continuous task. The KAT is very easy to perform for the children and applicable in clinical settings.
Only AROM of the wrist showed a positive correlation with the KAT outcome measures.
BTX-A seems to have a direct, inverse effect on MT, END, and IP-E in the discrete tasks, when a high appeal is made on the accuracy and control of braking movements. On the other hand, there is a positive effect on MT and IP-E in continuous tasks, when speed is important and less accuracy is demanded.
Muscle force decreased immediately after BTX-A, showing the direct effect of BTX-A.
